Magali Le Goff

Magali Le Goff

Director, Regulatory Sciences & Scientific Writing

  • Regulatory and Scientific Writing
    • Global Development of Drugs and Medical Devices
    • Clinical development and clinical studies
    • Clinical CTD modules
  • Project management

Magali has gained an extensive experience in Regulatory and Scientific Writing after working as a Principal Medical Writer for 8 years in a Consultancy Medical Writing company.

Magali is the director of Regulatory Sciences and Scientific Writing, leading the Global Scientific Writing team and contributing to regulatory expertise in the global development and registration of pharmaceutical products.  

Contacter
Magali Le Goff Director Regulatory Sciences & Scientific Writing at BlueReg Group

Education

Magali earned her PhD in Ophthalmology and Biochemistry from the University of Manchester, UK. 

 

About Magali

Magali has gained an extensive experience in Regulatory and Scientific Writing after working as a Principal Medical Writer for 8 years in a Consultancy Medical Writing company.

Magali is the director of Regulatory Sciences and Scientific Writing, leading the Global Scientific Writing team and contributing to regulatory expertise in the global development and registration of pharmaceutical products.

Background/Past experience

Prior to joining BlueReg Pharma Consulting, Magali was at Scinopsis, where she managed a team of 4 senior/junior medical writers. Her main role was to lead/supervise the writing of clinical CTD modules for submissions in Europe and in the US. She was also in charge of writing regulatory documents required during the global clinical development of drugs/medical devices (e.g. protocols, IBs, study reports) in a wide range of therapeutic areas including Ophthalmology, Oncology, Dermatology, Respiratory and Rare Diseases.

She started her career as a Postdoctoral/Research Fellow at the University of Manchester where she investigated the role of the extracellular matrix in ocular disorders including diabetic retinopathy and age-related macular degeneration. During her time as a researcher, she authored 8 peer-reviewed articles and 2 invited reviews.

Magali has joined BlueReg as Director, Regulatory Sciences and Scientific Writing in February 2020 managing the Global Scientific Writing team.